https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20210929-1443822/1443822_ldl6.pdf
Sight Sciences’ Q4 Earnings, FY22 Guidance Beat Street View
Sight Sciences Inc (NASDAQ: SGHT) has
Related Posts
Vera Therapeutics Q3 EPS $(0.91) Down From $(0.36) YoY
Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.
Credit Acceptance Insider Trades $21.08 Million In Company Stock
Scott Vassalluzzo, 10% Owner at Credit Acceptance (NASDAQ:CACC), made a large insider sell on September 9, according to a new SEC filing.